These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
747 related items for PubMed ID: 9663255
1. The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings. Friess H, Duarte R, Kleeff J, Fukuda A, Tang WH, Graber H, Schilling M, Zimmermann A, Korc M, Büchler MW. Surgery; 1998 Jul; 124(1):79-86. PubMed ID: 9663255 [Abstract] [Full Text] [Related]
2. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells. Zhang LP, Takahara T, Yata Y, Furui K, Jin B, Kawada N, Watanabe A. J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395 [Abstract] [Full Text] [Related]
3. Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis. Friess H, Cantero D, Graber H, Tang WH, Guo X, Kashiwagi M, Zimmermann A, Gold L, Korc M, Büchler MW. Gastroenterology; 1997 Sep; 113(3):904-13. PubMed ID: 9287983 [Abstract] [Full Text] [Related]
4. Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor. Zheng Q, Tang ZY, Xue Q, Shi DR, Song HY, Tang HB. J Cancer Res Clin Oncol; 2000 Nov; 126(11):641-6. PubMed ID: 11079728 [Abstract] [Full Text] [Related]
5. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy. Lundgren CH, Sawa H, Sobel BE, Fujii S. Circulation; 1994 Oct; 90(4):1927-34. PubMed ID: 7923681 [Abstract] [Full Text] [Related]
6. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis. Leonardi A, Brun P, Sartori MT, Cortivo R, Dedominicis C, Saggiorato G, Abatangelo G, Secchi AG. Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903 [Abstract] [Full Text] [Related]
7. Serine proteinase activation in esophageal cancer. Tang WH, Friess H, Kekis PB, Martignoni ME, Fukuda A, Roggo A, Zimmerman A, Büchler MW. Anticancer Res; 2001 Apr; 21(4A):2249-58. PubMed ID: 11724279 [Abstract] [Full Text] [Related]
8. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness. Bryan L, Paugh BS, Kapitonov D, Wilczynska KM, Alvarez SM, Singh SK, Milstien S, Spiegel S, Kordula T. Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934 [Abstract] [Full Text] [Related]
9. Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system. Ramont L, Pasco S, Hornebeck W, Maquart FX, Monboisse JC. Exp Cell Res; 2003 Nov 15; 291(1):1-10. PubMed ID: 14597403 [Abstract] [Full Text] [Related]
10. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts. Allan EH, Martin TJ. J Cell Physiol; 1995 Dec 15; 165(3):521-9. PubMed ID: 7593231 [Abstract] [Full Text] [Related]
11. Induction of the plasminogen activator system by mechanical stimulation of human bronchial epithelial cells. Chu EK, Cheng J, Foley JS, Mecham BH, Owen CA, Haley KJ, Mariani TJ, Kohane IS, Tschumperlin DJ, Drazen JM. Am J Respir Cell Mol Biol; 2006 Dec 15; 35(6):628-38. PubMed ID: 16794260 [Abstract] [Full Text] [Related]
12. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle. Nordengren J, Pilka R, Noskova V, Ehinger A, Domanski H, Andersson C, Høyer-Hansen G, Hansson SR, Casslén B. Mol Hum Reprod; 2004 Sep 15; 10(9):655-63. PubMed ID: 15243126 [Abstract] [Full Text] [Related]
13. Expression of urokinase-type plasminogen activator and its receptor during ovarian follicular development. Li M, Karakji EG, Xing R, Fryer JN, Carnegie JA, Rabbani SA, Tsang BK. Endocrinology; 1997 Jul 15; 138(7):2790-9. PubMed ID: 9202219 [Abstract] [Full Text] [Related]
14. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori. Iwamoto J, Mizokami Y, Takahashi K, Nakajima K, Ohtsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokobe K, Ito M, Takehara H, Matsuoka T. Scand J Gastroenterol; 2005 Jul 15; 40(7):783-93. PubMed ID: 16109653 [Abstract] [Full Text] [Related]
16. Activation of the serine proteinase system in chronic kidney rejection. Tang WH, Friess H, di Mola FF, Schilling M, Maurer C, Graber HU, Dervenis C, Zimmermann A, Büchler MW. Transplantation; 1998 Jun 27; 65(12):1628-34. PubMed ID: 9665081 [Abstract] [Full Text] [Related]
17. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R, Schaaf A. Int J Oncol; 2009 Jan 27; 34(1):15-23. PubMed ID: 19082473 [Abstract] [Full Text] [Related]
18. Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints. Busso N, Péclat V, So A, Sappino AP. Ann Rheum Dis; 1997 Sep 27; 56(9):550-7. PubMed ID: 9370880 [Abstract] [Full Text] [Related]
19. Regulated localization confers multiple functions on the protease urokinase plasminogen activator. Wells JM, Strickland S. J Cell Physiol; 1997 May 27; 171(2):217-25. PubMed ID: 9130470 [Abstract] [Full Text] [Related]
20. Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases--a comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases. Fisher JL, Field CL, Zhou H, Harris TL, Henderson MA, Choong PF. Breast Cancer Res Treat; 2000 May 27; 61(1):1-12. PubMed ID: 10930085 [Abstract] [Full Text] [Related] Page: [Next] [New Search]